ABOUT THE SPEAKER
Faith Osier - Infectious disease doctor
Faith Osier is studying how humans acquire immunity to malaria and developing new malaria vaccines.

Why you should listen

Faith Osier works to understand how humans acquire immunity to malaria and intends to use this knowledge to design highly effective vaccines. Her studies focus on infections with the parasite Plasmodium falciparum, which leads to nearly half a million deaths in Africa each year. She demonstrated that Kenyan children who did not get sick after a malaria infection had high levels of antibodies against combinations of specific proteins found within the parasite. Subsequently, her studies in immune African adults revealed that there were in fact many additional parasite proteins that could be considered for malaria vaccines. To verify her results, she designed a massive study involving children and adults from 15 different geographical locations in Africa. She designed KILchip, a custom protein microarray that enabled her team to analyze antibody responses to more than 100 intentionally selected malaria proteins in these human blood samples. Her research group also studies the mechanisms by which these antibodies kill malaria parasites.

Osier is a Professor of Malaria Immunology in the Nuffield Deptartment of Medicine at the University of Oxford, UK. She has two research laboratories: one in the Biosciences Deptartment of the KEMRI-Wellcome Trust Research Programme in Kilifi, Kenya, and the other in the Parasitology Deptartment of Heidelberg University Hospital in Heidelberg, Germany. She has won multiple awards for her work including the Royal Society Pfizer Award (UK) and the prestigious Sofja Kovalevskaja Award from the Alexander von Humboldt Foundation. She holds major research grants from the Wellcome Trust, is an MRC African Research Leader and an EDCTP Senior Fellow. She is also a fellow of the African Academy of Sciences, an advisor to the Executive Committee of the Federation of African Immunological Societies and the vice-president/president-elect of the International Union of Immunological Societies. She was named a TED Fellow in 2018. She is passionate about training African scientists to excel and deliver the medical interventions that are urgently needed on the continent.

More profile about the speaker
Faith Osier | Speaker | TED.com
TED2018

Faith Osier: The key to a better malaria vaccine

Filmed:
1,593,424 views

The malaria vaccine was invented more than a century ago -- yet each year, hundreds of thousands of people still die from the disease. How can we improve this vital vaccine? In this informative talk, immunologist and TED Fellow Faith Osier shows how she's combining cutting-edge technology with century-old insights in the hopes of creating a new vaccine that eradicates malaria once and for all.
- Infectious disease doctor
Faith Osier is studying how humans acquire immunity to malaria and developing new malaria vaccines. Full bio

Double-click the English transcript below to play the video.

00:13
There are 200 million clinical cases
0
1754
4666
00:18
of falciparum malaria
in Africa every year,
1
6444
4403
00:22
resulting in half a million deaths.
2
10871
2920
00:26
I would like to talk to you
about malaria vaccines.
3
14395
3809
00:30
The ones that we have made to date
are simply not good enough.
4
18807
5598
00:36
Why?
5
24998
1150
00:38
We've been working at it
for 100 plus years.
6
26474
3984
00:42
When we started, technology was limited.
7
30950
3606
00:46
We could see just a tiny fraction
of what the parasite really looked like.
8
34966
6881
00:54
Today, we are awash with technology,
9
42466
3365
00:57
advanced imaging and omics platforms --
10
45855
4055
01:01
genomics, transcriptomics, proteomics.
11
49934
4210
01:06
These tools have given us a clearer view
12
54620
3873
01:10
of just how complex
the parasite really is.
13
58517
4293
01:15
However, in spite of this,
14
63365
2627
01:18
our approach to vaccine design
has remained pretty rudimentary.
15
66016
5500
01:24
To make a good vaccine,
we must go back to basics
16
72040
4420
01:28
to understand how our bodies
handle this complexity.
17
76484
4525
01:34
People who are frequently
infected with malaria
18
82460
4197
01:38
learn to deal with it.
19
86681
1467
01:40
They get the infection,
but they don't get ill.
20
88689
3301
01:44
The recipe is encoded in antibodies.
21
92688
3619
01:48
My team went back to our complex parasite,
22
96903
3984
01:52
probed it with samples from Africans
who had overcome malaria
23
100911
4928
01:57
to answer the question:
24
105863
1825
01:59
"What does a successful
antibody response look like?"
25
107712
4047
02:04
We found over 200 proteins,
26
112212
3302
02:07
many of which are not
on the radar for malaria vaccines.
27
115538
4213
02:12
My research community may be missing out
important parts of the parasite.
28
120141
5182
02:18
Until recently, when one had identified
a protein of interest,
29
126283
5265
02:23
they tested whether it might be
important for a vaccine
30
131572
3603
02:27
by conducting a cohort study.
31
135199
2429
02:30
This typically involved about 300
participants in a village in Africa,
32
138307
5572
02:35
whose samples were analyzed to see
33
143903
2809
02:38
whether antibodies to the protein
would predict who got malaria
34
146736
5706
02:44
and who did not.
35
152466
1246
02:46
In the past 30 years,
36
154323
2103
02:48
these studies have tested
a small number of proteins
37
156450
4778
02:53
in relatively few samples
38
161252
2372
02:55
and usually in single locations.
39
163648
2667
02:58
The results have not been consistent.
40
166782
3079
03:02
My team essentially collapsed
30 years of this type of research
41
170956
6081
03:09
into one exciting experiment,
conducted over just three months.
42
177061
4941
03:14
Innovatively, we assembled 10,000 samples
43
182609
4222
03:18
from 15 locations
in seven African countries,
44
186855
4413
03:23
spanning time, age
and the variable intensity
45
191292
4222
03:27
of malaria experienced in Africa.
46
195538
2682
03:30
We used omics intelligence
to prioritize our parasite proteins,
47
198585
5659
03:36
synthesize them in the lab
48
204268
2000
03:38
and in short, recreated
the malaria parasite on a chip.
49
206292
4804
03:43
We did this in Africa,
and we're very proud of that.
50
211585
3467
03:47
(Applause)
51
215379
6175
03:53
The chip is a small glass slide,
52
221578
3111
03:56
but it gives us incredible power.
53
224713
2396
04:00
We simultaneously gathered data
on over 100 antibody responses.
54
228007
6167
04:06
What are we looking for?
55
234592
1600
04:08
The recipe behind a successful
antibody response,
56
236679
4635
04:13
so that we can predict
what might make a good malaria vaccine.
57
241338
4365
04:18
We're also trying to figure out
58
246680
1873
04:20
exactly what antibodies
do to the parasite.
59
248577
3547
04:24
How do they kill it?
60
252482
1555
04:26
Do they attack from multiple angles?
Is there synergy?
61
254061
3722
04:29
How much antibody do you need?
62
257807
2000
04:32
Our studies suggest that having
a bit of one antibody won't be enough.
63
260188
5889
04:38
It might take high
concentrations of antibodies
64
266458
3183
04:41
against multiple parasite proteins.
65
269665
2516
04:44
We're also learning that antibodies
kill the parasite in multiple ways,
66
272673
5015
04:49
and studying any one of these in isolation
may not adequately reflect reality.
67
277712
5944
04:56
Just like we can now see the parasite
in greater definition,
68
284454
4476
05:00
my team and I are focused
69
288954
1992
05:02
on understanding how our bodies
overcome this complexity.
70
290970
4737
05:08
We believe that this could provide
the breakthroughs that we need
71
296012
4437
05:12
to make malaria history
through vaccination.
72
300473
3736
05:16
Thank you.
73
304719
1151
05:17
(Applause)
74
305894
1703
05:19
(Cheers)
75
307621
2396
05:22
(Applause)
76
310041
5752
05:27
Shoham Arad: OK, how close
are we actually to a malaria vaccine?
77
315817
3487
05:32
Faith Osier: We're just
at the beginning of a process
78
320281
2857
05:35
to try and understand
what we need to put in the vaccine
79
323162
3984
05:39
before we actually start making it.
80
327170
2533
05:41
So, we're not really close to the vaccine,
but we're getting there.
81
329727
3833
05:45
SA: And we're hopeful.
82
333584
1241
05:46
FO: And we're very hopeful.
83
334849
1800
05:49
SA: Tell me about SMART,
tell me what does it stand for
84
337323
3246
05:52
and why is it important to you?
85
340593
2040
05:54
FO: So SMART stands for South-South
Malaria Antigen Research Partnership.
86
342657
6383
06:01
The South-South
is referring to us in Africa,
87
349477
4262
06:05
looking sideways to each other
in collaboration,
88
353763
4505
06:10
in contrast to always looking to America
and looking to Europe,
89
358292
4206
06:14
when there is quite
some strength within Africa.
90
362522
3037
06:17
So in SMART,
91
365997
1164
06:19
apart from the goal that we have,
to develop a malaria vaccine,
92
367185
3940
06:23
we are also training African scientists,
93
371149
2445
06:25
because the burden
of disease in Africa is high,
94
373618
3229
06:28
and you need people who will continue
to push the boundaries
95
376871
3963
06:32
in science, in Africa.
96
380858
1658
06:34
SA: Yes, yes, correct.
97
382540
2046
06:36
(Applause)
98
384610
3191
06:40
OK, one last question.
99
388053
1548
06:41
Tell me, I know you
mentioned this a little bit,
100
389625
2754
06:44
but how would things actually change
if there were a malaria vaccine?
101
392403
3254
06:48
FO: We would save
half a million lives every year.
102
396732
3738
06:53
Two hundred million cases.
103
401256
1826
06:55
It's estimated that malaria costs Africa
12 billion US dollars a year.
104
403106
6808
07:02
So this is economics.
105
410278
1396
07:03
Africa would simply thrive.
106
411698
2268
07:06
SA: OK. Thank you, Faith.
107
414626
1501
07:08
Thank you so much.
108
416151
1198
07:09
(Applause)
109
417373
1396

▲Back to top

ABOUT THE SPEAKER
Faith Osier - Infectious disease doctor
Faith Osier is studying how humans acquire immunity to malaria and developing new malaria vaccines.

Why you should listen

Faith Osier works to understand how humans acquire immunity to malaria and intends to use this knowledge to design highly effective vaccines. Her studies focus on infections with the parasite Plasmodium falciparum, which leads to nearly half a million deaths in Africa each year. She demonstrated that Kenyan children who did not get sick after a malaria infection had high levels of antibodies against combinations of specific proteins found within the parasite. Subsequently, her studies in immune African adults revealed that there were in fact many additional parasite proteins that could be considered for malaria vaccines. To verify her results, she designed a massive study involving children and adults from 15 different geographical locations in Africa. She designed KILchip, a custom protein microarray that enabled her team to analyze antibody responses to more than 100 intentionally selected malaria proteins in these human blood samples. Her research group also studies the mechanisms by which these antibodies kill malaria parasites.

Osier is a Professor of Malaria Immunology in the Nuffield Deptartment of Medicine at the University of Oxford, UK. She has two research laboratories: one in the Biosciences Deptartment of the KEMRI-Wellcome Trust Research Programme in Kilifi, Kenya, and the other in the Parasitology Deptartment of Heidelberg University Hospital in Heidelberg, Germany. She has won multiple awards for her work including the Royal Society Pfizer Award (UK) and the prestigious Sofja Kovalevskaja Award from the Alexander von Humboldt Foundation. She holds major research grants from the Wellcome Trust, is an MRC African Research Leader and an EDCTP Senior Fellow. She is also a fellow of the African Academy of Sciences, an advisor to the Executive Committee of the Federation of African Immunological Societies and the vice-president/president-elect of the International Union of Immunological Societies. She was named a TED Fellow in 2018. She is passionate about training African scientists to excel and deliver the medical interventions that are urgently needed on the continent.

More profile about the speaker
Faith Osier | Speaker | TED.com